National Health Investors (NYSE:NHI) Announces FY 2026 Earnings Guidance

Posted by Brenda Bartman on Nov 10th, 2026

National Health Investors (NYSE:NHI – Get Free Report) issued an update on its FY 2026 earnings guidance on Tuesday morning. The company provided EPS guidance of 4.680-4.700 for the period, compared to the consensus estimate of 4.760.

Wall Street Analysts Forecast Growth

NHI has been the topic of several recent research reports. BMO Capital Markets reiterated an “outperform” rating on shares of National Health Investors in a research note on Wednesday, September 23rd. Zacks Research raised National Health Investors from a “strong sell” rating to a “hold” rating in a research report on Tuesday, September 29th. Truist Financial lowered their price target on shares of National Health Investors from $81.00 to $80.00 and set a “buy” rating on the stock in a research report on Wednesday, September 2nd. Wells Fargo & Company cut their target price on National Health Investors from $78.00 to $68.00 and set an “equal weight” rating for the company in a research note on Monday, October 19th. Finally, National Bank Financial set a $79.00 price objective on National Health Investors in a research report on Wednesday, September 9th. Five analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, National Health Investors currently has a consensus rating of “Moderate Buy” and a consensus price target of $81.00.

View Our Latest Stock Report on National Health Investors

National Health Investors Price Performance

NHI stock traded down $4.24 during trading on Tuesday, hitting $66.99. The stock had a trading volume of 50,337 shares, compared to its average volume of 406,065. National Health Investors has a twelve month low of $63.51 and a twelve month high of $91.38. The stock has a market capitalization of $3.29 billion, a P/E ratio of 19.40, a PEG ratio of 4.54 and a beta of 0.51. The company has a debt-to-equity ratio of 0.81, a current ratio of 6.78 and a quick ratio of 6.78. The company’s 50-day moving average price is $67.80 and its two-hundred day moving average price is $76.13.

National Health Investors (NYSE:NHI – Get Free Report) last announced its earnings results on Monday, November 9th. The real estate investment trust reported $11.47 EPS for the quarter, beating analysts’ consensus estimates of $1.18 by $10.29. National Health Investors had a return on equity of 10.89% and a net margin of 38.56%. The company had revenue of $113.48 million during the quarter, compared to analysts’ expectations of $68.53 million. As a group, research analysts predict that National Health Investors will post 4.76 EPS for the current fiscal year.

National Health Investors Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, January 29th. Investors of record on Thursday, December 31st will be paid a $0.92 dividend. The ex-dividend date of this dividend is Thursday, December 31st. This represents a $3.68 dividend on an annualized basis and a yield of 5.5%. National Health Investors’s dividend payout ratio (DPR) is currently 108.67%.

Trending Headlines about National Health Investors

Here are the key news stories impacting National Health Investors this week:

Positive Sentiment: NHI reported third-quarter EPS of $11.47 and revenue of $113.5 million, above consensus estimates of $1.18 and $68.5 million, respectively. The unusually large EPS beat contrasts with the weaker FFO result below. NHI Announces Third Quarter 2026 Results
Positive Sentiment: The REIT declared a quarterly dividend of $0.92 per share, equivalent to $3.68 annually and a reported yield of 5.1%. One separate headline cited $0.94, so reports differ on the amount. National Health Investors declares dividend
Negative Sentiment: FY 2026 EPS guidance is $4.68–$4.70, below the $4.76 analyst consensus, signaling a slightly weaker outlook than expected. 2026 earnings guidance
Negative Sentiment: Quarterly FFO was $1.12 per share, missing the $1.17 consensus and down from $1.32 a year earlier. FFO is an important operating measure for REITs, tempering the strong reported EPS and revenue figures. NHI misses Q3 FFO estimates

National Health Investors Company Profile

(Get Free Report)

National Health Investors, Inc (NYSE: NHI) is a real estate investment trust that owns and finances properties used for senior housing and health care. Founded in 1991, the company is headquartered in Murfreesboro, Tennessee.

NHI’s portfolio includes senior housing communities, such as independent living, assisted living and memory care properties, as well as skilled nursing facilities. It typically works with health care operators through property leases and mortgage loans.

The company serves markets across the United States.